Evidence map›Paper›PMID 27184239›Full record

ArticleOrganic & biomolecular chemistry2016

Assessment of reagents for selenocysteine conjugation and the stability of selenocysteine adducts.

Lee Pedzisa, Xiuling Li, Christoph Rader, William R Roush

Open access · greenAbstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lee PedzisaDepartment of Chemistry, The Scripps Research Institute, Scripps Florida, Jupiter FL 33458, USA. roush@scripps.edu.
Xiuling Li
Christoph Rader
William R Roush
Scripps Research Institute · US

Funding

Chemically Programmed Bispecific Antibodies for Cancer TherapyR01CA181258 · NCI · SCRIPPS FLORIDA · PI RADER, CHRISTOPH · 2014 to 2018
$2.0M
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic LeukemiaU01CA174844 · NCI · SCRIPPS FLORIDA · PI RADER, CHRISTOPH · 2013 to 2015
$1.4M
NCI NIH HHS R01 CA181258NCI NIH HHS U01 CA174844
6 · The paper itself

Abstract

Conventional antibody-drug conjugates (ADCs) are heterogeneous mixtures that have poor pharmacokinetic properties and decreased efficacy relative to homogenous ADCs. Furthermore, ADCs that are maleimide-based often have inadequate circulatory stability, which can result in premature drug release with consequent off-target toxicities. Selenocysteine-modified antibodies have been developed that allow site-specific antibody conjugation, yielding homogeneous ADCs. Herein, we survey several electrophilic functional groups that react with selenocystine with high efficiency. Several of these result in conjugates with stabilities that are superior to maleimide conjugates. Among these, the allenamide functional group reacts with notably high efficiency, leads to conjugates with remarkable stability, and shows exquisite selectivity for selenocysteine conjugation.

Indexed as

Drug StabilityMaleimidesSelenocysteinemaleimideMaleimidesSelenocysteine

Identifiers

PMID27184239
PMCPMC4887430
OpenAlexW2408461971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.